Edgestream Partners, L.P.

Position in PBH — Prestige Consumer Healthcare Inc.

CIK 1535061 Princeton, NJ

Position in PBH

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$6,449,405

-$3,941,720 QoQ

Shares Held

108,814

-35.4% QoQ

Ownership

0.230%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

6 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Edgestream Partners, L.P. holds $28,592,165 across 5 Drug Manufacturers - Specialty & Generic names. PBH ranks #3 (22.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	77,506	$9,161,984
2	NBIX	Neurocrine Biosciences Inc	50,587	$6,664,331
3	PBH	Prestige Consumer Healthcare Inc. This page	108,814	$6,449,405
4	VTRS	Viatris Inc	329,276	$4,448,518
5	ALKS	Alkermes plc.	52,826	$1,867,927

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,449,405	108,814	-35.4%	Shares	Sole	2026-05-18
2025-12-31	$10,391,125	168,441	+54.5%	Shares	Sole	2026-02-13
2025-09-30	$6,803,097	109,024	-19.5%	Shares	Sole	2025-11-12
2025-06-30	$10,820,553	135,511	+147.5%	Shares	Sole	2025-08-13
2024-09-30	$3,947,258	54,747	+519.4%	Shares	Sole	2024-11-14
2023-09-30	$505,502	8,839	—	Shares	Sole	2023-11-15
No filing history on record for this holder in this stock.